Description
Scope of the Report The report titled“ US Thyroid Cancer Market: Trends and Opportunities( 2015-2019)” provides an insight into the overall thyroid cancer market of the United States of America. The report analyzes in detail the segments of Thyroid Cancer Market that includes Thyroid Cancer Diagnostics Surgeries, Thyroid Histopathology Market, Thyroid Cancer Secondary Surgery and Thyroid Cancer Hormone Replacement Market. The report assesses thyroid cancer types, stages and incidence rate of the disease and also discusses the factors that will result in the demand and growth of the market. Further, companies like Veracyte Inc., Mylan Inc., Forest Laboratories, Abott Laboratories and Oxigene Inc. are profiled in the report.
Request a sample of this report @ http:// www. orbisresearch. com / contacts / request-sample / 185273.
Product Coverage Thyroid Cancer Diagnostic Surgeries Thyroid Cancer Histopathology Market Thyroid Cancer Secondary Surgery Thyroid Cancer Hormone Replacement FNA biopsies
Company Coverage Veracyte Inc. Mylan Inc. Forest Laboratories Abott Laboratories Oxigene Inc.
Purchase a copy of US Thyroid Cancer Market visit @ http:// www. orbisresearch. com / contact / purchase / 185273 For more information contact sales @ orbisresearch. com.
Executive Summary Thyroid cancer, a type of malignant cancer, initiate from follicular and par follicular thyroid cells. The most effective treatment of thyroid cancer is surgical removal of thyroid gland followed by radioactive ablation and thyroid stimulating hormone( TSH) suppression therapy. Chemotherapy is also used in cases of metastasis and progressive stage of thyroid cancer. Thyroid cancer market is accelerating in the United States since 2010 and it is a disease which is fast on the rise. Incidence has more than doubled since the early 1970s, and for women, it is the cancer with the fastest-growing number of new cases.
On the back of high incidence of thyroid cancer, it is anticipated that the thyroid cancer market in US will observe impressive double digit growth in next five years. The thyroid cancer diagnosis market is segmented into diagnostic surgeries, histopathology, secondary surgery and annual new patient hormone replacement therapy. The diagnostic technology has improved since 2011 and with use of Afirma GEC test and Afirma FNA; the detection of even minor nodules has become possible.
www. orbisresearch. com; + 1( 214) 884-6817; + 9120-64101019